Eleison Pharmaceuticals
Pre-clinicalDevelops cancer therapies that modulate cellular metabolism to overcome drug resistance.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $35M
About
Develops cancer therapies that modulate cellular metabolism to overcome drug resistance.
Small Molecules
Funding History
2Total raised:$35M
Series B$25MJun 15, 2022
Series A$10MJan 15, 2021